These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 19186200

  • 1. Cost-effectiveness of childhood rotavirus vaccination in Taiwan.
    Wu CL, Yang YC, Huang LM, Chen KT.
    Vaccine; 2009 Mar 04; 27(10):1492-9. PubMed ID: 19186200
    [Abstract] [Full Text] [Related]

  • 2. Cost-effectiveness and potential impact of rotavirus vaccination in the United States.
    Widdowson MA, Meltzer MI, Zhang X, Bresee JS, Parashar UD, Glass RI.
    Pediatrics; 2007 Apr 04; 119(4):684-97. PubMed ID: 17403839
    [Abstract] [Full Text] [Related]

  • 3. Cost-effectiveness of a pentavalent human-bovine reassortant rotavirus vaccine for children ≤5 years of age in Taiwan.
    Itzler RF, Chen PY, Lac C, El Khoury AC, Cook JR.
    J Med Econ; 2011 Apr 04; 14(6):748-58. PubMed ID: 21919673
    [Abstract] [Full Text] [Related]

  • 4. Costs of diarrheal disease and the cost-effectiveness of a rotavirus vaccination program in kyrgyzstan.
    Flem ET, Latipov R, Nurmatov ZS, Xue Y, Kasymbekova KT, Rheingans RD.
    J Infect Dis; 2009 Nov 01; 200 Suppl 1():S195-202. PubMed ID: 19817600
    [Abstract] [Full Text] [Related]

  • 5. Cost-effectiveness of rotavirus vaccination: exploring caregiver(s) and "no medical care'' disease impact in Belgium.
    Bilcke J, Van Damme P, Beutels P.
    Med Decis Making; 2009 Nov 01; 29(1):33-50. PubMed ID: 18948433
    [Abstract] [Full Text] [Related]

  • 6. Impact of transmission dynamics on the cost-effectiveness of rotavirus vaccination.
    Shim E, Galvani AP.
    Vaccine; 2009 Jun 19; 27(30):4025-30. PubMed ID: 19389452
    [Abstract] [Full Text] [Related]

  • 7. Cost-effectiveness of universal rotavirus vaccination in reducing rotavirus gastroenteritis in Ireland.
    Tilson L, Jit M, Schmitz S, Walsh C, Garvey P, McKeown P, Barry M.
    Vaccine; 2011 Oct 06; 29(43):7463-73. PubMed ID: 21821085
    [Abstract] [Full Text] [Related]

  • 8. Potential impact and cost-effectiveness analysis of rotavirus vaccination of children in Israel.
    Chodick G, Waisbourd-Zinman O, Shalev V, Kokia E, Rabinovich M, Ashkenazi S.
    Eur J Public Health; 2009 Jun 06; 19(3):254-9. PubMed ID: 19221026
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of cost-effectiveness of live oral pentavalent reassortant rotavirus vaccine introduction in Ghana.
    Abbott C, Tiede B, Armah G, Mahmoud A.
    Vaccine; 2012 Mar 28; 30(15):2582-7. PubMed ID: 22321664
    [Abstract] [Full Text] [Related]

  • 10. Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries.
    Tu HA, Rozenbaum MH, Coyte PC, Li SC, Woerdenbag HJ, Postma MJ.
    Vaccine; 2012 Feb 14; 30(8):1521-8. PubMed ID: 22119590
    [Abstract] [Full Text] [Related]

  • 11. Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam.
    Fischer TK, Anh DD, Antil L, Cat ND, Kilgore PE, Thiem VD, Rheingans R, Tho le H, Glass RI, Bresee JS.
    J Infect Dis; 2005 Nov 15; 192(10):1720-6. PubMed ID: 16235169
    [Abstract] [Full Text] [Related]

  • 12. The cost-effectiveness of rotavirus vaccination in Australia.
    Newall AT, Beutels P, Macartney K, Wood J, MacIntyre CR.
    Vaccine; 2007 Dec 17; 25(52):8851-60. PubMed ID: 18022735
    [Abstract] [Full Text] [Related]

  • 13. Cost of routine immunization of young children against rotavirus infection with Rotarix versus RotaTeq.
    Weycker D, Sofrygin O, Kemner JE, Pelton SI, Oster G.
    Vaccine; 2009 Aug 06; 27(36):4930-7. PubMed ID: 19555715
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Evaluating rotavirus vaccination in England and Wales. Part II. The potential cost-effectiveness of vaccination.
    Jit M, Edmunds WJ.
    Vaccine; 2007 May 16; 25(20):3971-9. PubMed ID: 17400341
    [Abstract] [Full Text] [Related]

  • 17. Potential epidemiological and economical impact of two rotavirus vaccines in Colombia.
    De la Hoz F, Alvis N, Narváez J, Cediel N, Gamboa O, Velandia M.
    Vaccine; 2010 May 14; 28(22):3856-64. PubMed ID: 20347057
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries.
    Rheingans RD, Antil L, Dreibelbis R, Podewils LJ, Bresee JS, Parashar UD.
    J Infect Dis; 2009 Nov 01; 200 Suppl 1():S16-27. PubMed ID: 19817595
    [Abstract] [Full Text] [Related]

  • 20. Cost-effectiveness of rotavirus vaccination as part of the national immunization program for Thai children.
    Chotivitayatarakorn P, Chotivitayatarakorn P, Poovorawan Y.
    Southeast Asian J Trop Med Public Health; 2010 Jan 01; 41(1):114-25. PubMed ID: 20578490
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.